In a woman undergoing in‑vitro fertilisation, how should a shortened activated partial thromboplastin time (aPTT) of 23.2 seconds be interpreted and managed?

Shortened aPTT in IVF Context: Interpretation and Management

A shortened aPTT of 23.2 seconds in a woman undergoing IVF most likely reflects elevated Factor VIII activity in a hypercoagulable state rather than a preanalytical error, and warrants prophylactic anticoagulation with LMWH during ovarian stimulation to prevent potentially life-threatening thrombosis.

Understanding the Shortened aPTT

The shortened aPTT (23.2 seconds vs. normal range typically 24-36 seconds) should not be dismissed as merely a collection artifact. Recent evidence demonstrates that:

• Only 5% of shortened aPTT cases are due to clotted samples 1
• Elevated Factor VIII activity is the primary cause, with 68% of patients with shortened aPTT having Factor VIII levels >150% 1
• This represents true in-vivo hypercoagulability in approximately 20% or more of cases 2

In the reproductive context specifically, shortened aPTT has been associated with recurrent pregnancy loss, with 27.3% of women with recurrent abortions demonstrating shortened aPTT and 36.4% showing elevated Factor VIII levels 3.

Critical Management in IVF Context

Anticoagulation is Strongly Recommended

The 2020 ACR guidelines for reproductive health conditionally recommend prophylactic anticoagulation with heparin or LMWH in patients with prothrombotic risk factors during ART procedures 4. The rationale is clear:

• Ovarian stimulation dramatically elevates estrogen levels, creating a hypercoagulable state
• The risk of organ- or life-threatening thrombosis greatly outweighs the low risk of bleeding from prophylactic anticoagulation 4
• Your patient's shortened aPTT indicates she is already in a hypercoagulable state before adding the thrombotic risk of supraphysiologic estrogen

Specific Anticoagulation Protocol

Prophylactic LMWH dosing 4:

• Enoxaparin 40 mg subcutaneously daily (most commonly used)
• Start at the beginning of ovarian stimulation
• Withhold 24-36 hours prior to oocyte retrieval
• Resume following retrieval

The prolonged aPTT should not be considered a contraindication to thromboprophylaxis, as guidelines specifically state that abnormal aPTT values do not preclude anticoagulation in hypercoagulable states 5.

Diagnostic Workup Before Proceeding

Before initiating IVF, evaluate:

1. Factor VIII activity level - This is the most likely cause of the shortened aPTT 1
2. Antiphospholipid antibodies (lupus anticoagulant, anticardiolipin, anti-β2-glycoprotein I) - These patients require anticoagulation during ART 4
3. Inflammatory markers (CRP, WBC) - Inflammation can elevate Factor VIII 1
4. Repeat aPTT on a fresh sample - If consistently shortened on multiple samples, this confirms in-vivo hypercoagulability rather than preanalytical error 6

Additional Considerations

Thrombotic Risk Assessment

A shortened aPTT has been associated with:

• Increased venous thromboembolism risk 7, 2
• Recurrent pregnancy loss 3
• Adverse cardiovascular events 2

Duration of Anticoagulation

The optimal duration has not been definitively studied, but should be determined in consultation with reproductive endocrinology. Consider continuing through:

• The entire stimulation cycle
• Through oocyte retrieval
• Potentially through early pregnancy if conception occurs

Monitoring During Treatment

• Platelet counts every 2-3 days to screen for heparin-induced thrombocytopenia (risk 1-5% with UFH, lower with LMWH) 8
• No routine aPTT monitoring needed with prophylactic LMWH dosing 9
• Clinical vigilance for signs/symptoms of thrombosis

Common Pitfalls to Avoid

1. Do not dismiss the shortened aPTT as a "lab error" without confirming on repeat testing - this represents real hypercoagulability in most cases
2. Do not delay IVF indefinitely - with appropriate anticoagulation, the procedure can proceed safely
3. Do not use therapeutic-dose anticoagulation unless there is documented thrombosis - prophylactic dosing is appropriate for primary prevention
4. Do not withhold anticoagulation due to the shortened aPTT itself - this is an indication for anticoagulation, not against it